Analysis of the fall‐related risk of pharmacotherapy in Czech hospitals: A case control study

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60076658%3A12110%2F19%3A43899806" target="_blank" >RIV/60076658:12110/19:43899806 - isvavai.cz</a>

Alternative codes found

RIV/00216208:11160/20:10407904

Result on the web

<a href="https://onlinelibrary.wiley.com/doi/full/10.1111/jep.13270" target="_blank" >https://onlinelibrary.wiley.com/doi/full/10.1111/jep.13270</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1111/jep.13270" target="_blank" >10.1111/jep.13270</a>

Result language

angličtina

Original language name

Analysis of the fall‐related risk of pharmacotherapy in Czech hospitals: A case control study

Original language description

Falls are among the major problems occurring in hospital setting, when drugs are viewed as important modifiable risk factor of falling. The aim was to analyse the effect of pharmacotherapy on the risk of falls in hospitalized patients. Methods A multicentre prospective case‐control study was conducted in 2017 retrieving data from four hospitals in South Bohemia, Czech Republic. An online database was constructed to collect patient and fall‐related data. Each fall that occurred during hospitalization was assigned to appropriate controls (no fall during hospitalization) based on gender, age, length of hospitalization, and the number of drugs. Univariate and multivariate correlations were performed with a significance level of P &lt; .05. Results A total of 222 fall cases (107 males; median age, 81 y) and 1076 controls (516 males; median age, 80 y) were included. According to the first ATC level classification, drugs from groups S, N, and P were significantly associated with fall‐related risk compared with controls (P &lt; .05); further analysis of ATC levels showed that only psycholeptics (N05), antipsychotics (N05A), and tiapride were significantly associated with falls. Regression analysis revealed use of psycholeptics N05 (OR = 2.06; 95% CI, 1.56‐2.76), or ophthalmologicals S01 (OR = 2.72; 95% CI, 1.37‐5.41), as factors with the highest fall‐related risk. Conclusions Apart from the commonly considered fall‐risk increasing drugs, other groups, such as ophthalmologicals, should also be considered; however, regarding clinical practice, it is difficult to evaluate the effects of individual drugs in the context of other risk factors of falls, due to the multifactorial nature of falls.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30302 - Epidemiology

Project

<a href="/en/project/NV16-33463A" target="_blank" >NV16-33463A: Analysis of factors influencing the risk of falls - opportunities of involvement of nurses and pharmacists in minimization of the risk</a><br>

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year

2019

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Journal of Evaluation in Clinical Practice

ISSN

1356-1294

e-ISSN

—

Volume of the periodical

25

Issue of the periodical within the volume

9

Country of publishing house

US - UNITED STATES

Number of pages

10

Pages from-to

1-10

UT code for WoS article

000484719400001

EID of the result in the Scopus database

—